PROGNOSTIC VALUE OF sST2 AND NT- proBNP BIOMARKERS IN PREDICTING CARDIOVASCULAR EVENTS IN CHRONIC HEART FAILURE

Main Article Content

Makhsudov O.M.

Abstract

 CHF with reduced left ventricular ejection fraction is characterized by a high risk of rehospitalization and cardiovascular death. Biomarkers NT- proBNP and sST2 reflect hemodynamic stress, fibrosis, and myocardial remodeling .


 

Article Details

Section

Articles

References

1.McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. – 2021. – Vol. 42, No. 36. – P. 3599–3726.

2.Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure // Circulation. – 2022. – Vol. 145, No. 18. – P. e895–e1032.

3.Januzzi JL Jr., Rehman SU, Mohammed AA, et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction // Journal of the American College of Cardiology. – 2011. – Vol. 58, No. 18. – P. 1881–1889.

4.Ky B., French B., McCloskey K., et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure // Circulation: Heart Failure. – 2011. – Vol. 4, No. 2. – P. 180–187.

5.Aimo A., Vergaro G., Passino C., et al. Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis // JACC: Heart Failure. – 2017. – Vol. 5, No. 4. – P. 280–286.